Close Menu

Researchers at the Federal Polytechnic School in Lausanne, Switzerland, have killed two birds with one stone, so to speak. By knocking out the NCoR1 gene in mice, the researchers identified potential therapeutic avenues for both muscle-wasting diseases and type 2 diabetes, reports New Scientist's Andy Coghlan.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.